Granules India informs about press release

31 Jan 2022 Evaluate

Granules India has informed that it enclosed the press release on January 31st ,2022 titled ‘Granules Pharmaceuticals, Inc. concludes US FDA Audit with Three Minor Observations’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

561.70 -24.90 (-4.24%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.50
Dr. Reddys Lab 1293.00
Cipla 1314.10
Zydus Lifesciences 906.00
Lupin 2314.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×